No Data
Zhejiang Sunflower Great Health (300111.SZ): Expected net income to decline by 57% to 71% year-on-year in 2024.
On January 23rd, Gelonghui reported that Zhejiang Sunflower Great Health (300111.SZ) expects a net income of 6.3 million yuan to 9.4 million yuan in 2024, a decrease of 57% to 71% compared to the same period last year, with a non-net income of 5.3 million yuan to 7.9 million yuan. During the reporting period, the company's sales revenue remained basically flat year-on-year, while selling expenses decreased year-on-year, mainly due to the company's flexible adjustment of its sales strategy and the reduction of marketing expenses compared to the previous year. Additionally, during the reporting period, as the company repaid its interest-bearing liabilities, interest expenses decreased, leading to a year-on-year decline in financial expenses.
Sunflower: 2024 performance forecast
Recent 9.3% Pullback Isn't Enough to Hurt Long-term Zhejiang Sunflower Great Health (SZSE:300111) Shareholders, They're Still up 30% Over 5 Years
Zhejiang Sunflower Great Health's Chairman Resigns Early; Shares Up 5%
The chairman of zhejiang sunflower great health (300111.SZ), Cao Yang, has resigned.
Zhejiang sunflower great health (300111.SZ) announced that the board of directors recently received the resignation of the company's chairman, Mr. Cao Yang...
Sunflower: Third quarter report 2024
Zhejiang Sunflower Great Health Co., Ltd.'s (SZSE:300111) Popularity With Investors Is Under Threat From Overpricing
